A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

计划入组 24 人 · 首次发布于 2022 年 10 月 6 日

Steady State Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets

首次发布于 2012 年 7 月 6 日

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fed Conditions

首次发布于 2012 年 7 月 6 日

PRT-061103

Romiplostim biosimilar (Intas Pharmaceuticals)

factor VIII nanoparticle (Zoetic Pharmaceuticals)

Portola Pharmaceuticals, Inc.

United States

PORTOLA PHARMACEUTICALS INC

Spain

Portola Pharmaceuticals LLC

United States

Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer

AstraZeneca Voluntarily Withdraws Andexxa from US Market Following Fatal Thromboembolic Events

FDA Places Partial Clinical Hold on Kezar's Autoimmune Hepatitis Trial of Zetomipzomib